Diaz-ArrastiaR., KochanekP.M., BergoldP., KenneyK., MarxC.E., GrimesC.J., LohL.T., AdamL.T., OskvigD., CurleyK.C., and SalzerW. (2014). Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup. J. Neurotrauma, 31, 135–158.
2.
Tapia-PerezJ.H., Sanchez-AguilarM., Torres-CorzoJ.G., Gordillo-MoscosoA., Martinez-PerezP., MadevilleP., de la Cruz-MendozaE., and Chalita-WilliamsJ. (2008). Effect of rosuvastatin on amnesia and disorientation after traumatic brain injury (NCT003229758). J. Neurotrauma, 25, 1011–1017.
3.
Sánchez-AguilarM., Tapia-PérezJ.H., Sánchez-RodríguezJ.J., Viñas-RíosJ.M., Martínez-PérezP., de la Cruz-MendozaE., Sánchez-ReynaM., Torres-CorzoJ.G., and Gordillo-MoscosoA. (2013). Effect of rosuvastatin on cytokines after traumatic head injury. J. Neurosurg., 118, 669–675.
4.
SchneiderE.B., EfronD.T., MacKenzieE.J., RivaraF.P., NathensA.B., and JurkovichG.J. (2011). Premorbid statin use is associated with improved survival and functional outcomes in older head-injured individuals. J. Trauma, 71, 815–819.
5.
OrlandoA, Bar-OrD., SalottoloK., LevyA.S., MainsC.W., SloneD.S., and OffnerP.J. (2013). Unintentional discontinuation of statins may increase mortality after traumatic brain injury in elderly patients: a preliminary observation. J. Clin. Med. Res., 5, 168–173.
